{"url_path":"/sec/abbv/8-k/2026-07-06/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-06","source_url":"https://www.sec.gov/Archives/edgar/data/1551152/0001551152-26-000021-index.html","accession_number":"0001551152-26-000021","cik":"0001551152","ticker":"ABBV","issuer_name":"AbbVie Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1551152/0001551152-26-000021-index.html","primary_entity_key":"0001551152","primary_entity_name":"AbbVie Inc."},"word_count":333,"has_tables":true,"body_markdown":"abbv-20260706\n0001551152false00015511522026-07-062026-07-060001551152exch:XNYSus-gaap:CommonStockMember2026-07-062026-07-060001551152exch:XCHIus-gaap:CommonStockMember2026-07-062026-07-060001551152exch:XNYSabbv:Sec0.750SeniorNotesDue2027Member2026-07-062026-07-060001551152exch:XNYSabbv:Sec2.125SeniorNotesdue2028Member2026-07-062026-07-060001551152exch:XNYSabbv:Sec2625SeniorNotesDue2028Member2026-07-062026-07-060001551152exch:XNYSabbv:Sec2125SeniorNotesDue2029Member2026-07-062026-07-060001551152exch:XNYSabbv:Sec1.250SeniorNotesdue2031Member2026-07-062026-07-06\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n _____________________________________________________\n\nFORM 8-K\n\n \n\nCURRENT REPORT\n\nPursuant to Section 13 or 15(d) of the\n\nSecurities Exchange Act of 1934\n\n \n\nDate of Report (Date of earliest event reported): July 6, 2026\n\n \n\nABBVIE INC.\n\n(Exact name of registrant as specified in its charter)\n\nDelaware 001-35565 32-0375147\n\n(State or other Jurisdiction (Commission File Number) (IRS Employer\n\nof Incorporation)   Identification No.)\n\n _____________________________________________________\n\n1 North Waukegan Road\n\nNorth Chicago, Illinois 60064-6400\n\n(Address of principal executive offices)(Zip Code)\n\n \n\nRegistrant’s telephone number, including area code:  (847) 932-7900\n\n \n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n☐                      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n☐                      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n☐                      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n☐                      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class Trading Symbol(s) Name of each exchange on which registered\n\nCommon Stock, $0.01 Par Value ABBV New York Stock Exchange\n\nNYSE Texas\n\n0.750% Senior Notes due 2027ABBV27New York Stock Exchange\n\n2.125% Senior Notes due 2028ABBV28New York Stock Exchange\n\n2.625% Senior Notes due 2028ABBV28BNew York Stock Exchange\n\n2.125% Senior Notes due 2029ABBV29New York Stock Exchange\n\n1.250% Senior Notes due 2031ABBV31New York Stock Exchange\n\n \n\nIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\nEmerging growth company ☐   \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐"}